1. ReShape Lifesciences (RSLS) stock rosed on Wednesday on an U.S. Food and Drug Administration (FDA) update.
2. The company got a PMA supplement for its Lap-Band 2.0 FLEX. That news brings with it heavy trading of RSLS shares.
ReShape Lifesciences (NASDAQ:RSLS) stock is rosed higher on Wednesday following approval from the U.S. Food and Drug...
RSLS, ReShape Lifesciences, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
On 11/12/2021 Anthony Vendetti from Maxim Group brokerage Reiterated the Buy Rating for RSLS with a price target of $8.00.
That is more that 5X from the current price.
Looking forward to...
ReShape Lifesciences Inc (NASDAQ:RSLS) looks about ready to pop here! Setting up a possible resistance breakout trade. Technical indicators are supporting a continuation of the recent move higher. The RSI is moving back higher in the bullish zone and the MACD is crossing up. On my fireworks list.
ReShape Lifesciences (NASDAQ:RSLS) had a strong day as the stock closed up 65 cents or 26.21% on heavy volume. Friday’s high of $3.37 is now resistance for the continuation move. The stock is back on top over the 20-day EMA and MACD is showing positive momentum, while KD line also shows buy signal as %K line is on top of %D line.
Only did the fib retracement back til July because before that the levels are just absurdly higher. So sticking to some level of relevance, we can start to see what areas have materialized as potentially "important" in my opinion. For RSLS , the 786 fib has been a level of high traffic and pivot for the stock. It was previous support back in July and into August,...
- ReShape leader in weight loss market
- FDA approved Lap-Band manufacturing moved to the US
- eliminated debt overhang
- ReShape Marketplace - digital health solution
June 30, 2021: Cash and cash equivalents and restricted cash were $40.2 million.
ReShape Market Cap only 50.061M
Shares Outstanding 17.20M
On 7/1/2021, Ben Haynor from Alliance Global Partners...
On 6/17/2021 Alliance Global Partners brokerage Boosted the Price Target for RSLS ReShape Lifesciences stock from $12.00 to $18.50!
ReShape Lifesciences is America's premier weight-loss solutions company.
The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling...